National Comprehensive Cancer Network



About NCCN

Occult Primary Panel - Disclosures as of 4/20/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Mark Agulnik, MD

None

None

None

None

8/21/2013

Mary Anne Bergman

None

None

None

None

10/7/2013

Daniel W. Bowles, MD

None

None

None

None

9/6/2013

Justin M. Cates, MD, PhD

None

None

None

None

3/7/2013

Mihaela Cristea, MD

None

None

None

None

8/26/2013

Efrat Dotan, MD

MedImmune Inc.;
Biocompatibles;
Immunomedics Inc.

None

None

None

4/3/2014

Keith D. Eaton, MD, PhD

Genentech, Inc.;
OSI Pharmaceuticals, Inc.;
Nova Rx;
Pfizer Inc.

None

None

None

8/22/2013

David S. Ettinger, MD, FACP, FCCP

None

Boehringer Ingelheim GmbH;
Boehringer Ingelheim GmbH;
Eli Lilly and Company;
Eli Lilly and Company;
Genentech, Inc.;
Biodesix;
Biodesix;
Gilead;
Gilead;
Roche Laboratories, Inc.;
Roche Laboratories, Inc.

None

None

10/8/2013

Fayna Ferkle, PharmD

None

None

None

None

3/26/2014

Panagiotis M. Fidias, MD

None

Genentech, Inc.

None

None

2/7/2014

Deborah Freedman-Cass, PhD

None

None

None

None

3/7/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

David Gierada, MD

None

None

None

None

8/26/2013

G. Weldon Gilcrease, MD

       

Pending

Kelly Godby, MD

None

None

None

None

10/7/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Charles R. Handorf, MD, PhD

Pathwork Diagnostics

None

None

None

10/3/2013

Renuka Iyer, MD

None

None

None

None

9/19/2013

Renato Lenzi, MD

None

None

None

None

10/4/2013

Joan S. McClure, MS

None

None

None

None

8/13/2013

John Phay, MD

None

None

None

None

6/3/2013

Asif Rashid, MD

None

None

None

None

10/3/2013

Leonard Saltz, MD

Amgen Inc.;
Bayer HealthCare;
Bristol-Myers Squibb Company;
CureTech Ltd.;
Eli Lilly and Company;
Genentech, Inc.;
ImClone Systems Incorporated;
National Cancer Institute;
OSI Pharmaceuticals, Inc.;
Astellis;
Biothera;
Immunomedex;
Pfizer Inc.;
Roche Laboratories, Inc.;
Synta Pharmaceuticals Corp.;
Taiho Parmaceuticals Co., Ltd.

Bayer HealthCare;
Boehringer Ingelheim GmbH;
Genentech, Inc.;
Pfizer Inc.;
Roche Laboratories, Inc.

None

None

9/15/2013

Jillian Scavone

None

None

None

None

3/4/2014

Richard B. Schwab, MD

Galena Biopharma;
OBI Pharma

None

Samumed;
Sialix

None

9/24/2013

Lawrence N. Shulman, MD

None

None

None

None

8/26/2013

Jeffrey B. Smerage, MD, PhD

None

Amgen Inc.

None

None

4/11/2013

Marvaretta M Stevenson, MD

Pfizer Inc.

None

None

None

10/1/2013

Gauri R. Varadhachary, MD

None

None

None

None

9/11/2013

Jonathan S. Zager, MD

None

Amgen Inc.;
Delcath Systems;
IGEA;
Provectus

None

None

4/18/2014

Weining (Ken) Zhen, MD

None

None

None

None

8/15/2013